ONMD - NASDAQ
OneMedNet Corporation
$0.93
-40%OneMedNet Corporation provides clinical imaging solutions. It offers iRWD, a solution that utilizes AI to securely de-identify, search, and curate imaging data for its partner network consisting of medical and academic research institutions to generate progression in stages of medical research, discovery and diagnostics that span the field of life sciences. The company is based in Eden Prairie, Minnesota.
At a Glance
Live SnapshotOneMedNet Corporation Management Team
Mr. Aaron Green
Chief Executive Officer, President & Director
Compensation
$350,000
Mr. Robert L. Golden
Chief Financial Officer, Corporate Secretary & Director
Compensation
$48,000
Mr. James Wang
Chief Technology Officer
Mr. Delwin T. Coufal
Director of Marketing
Dr. Jeffrey Yu M.D.
Founder, Vice President, Chief Medical Officer & Chairman
Compensation
$300,000
Mr. Steven Chartier
Vice President of Engineering & Chief of Data
OneMedNet Corporation Insider Positioning
During the last 12 months, insiders have purchased $2.02M worth of ONMD shares, with no selling activity reported.
3 Months
0
0.00
0
0.00
+0
+$0
3-6 Months
0
0.00
0
0.00
+0
+$0
6-9 Months
42.5K
62.36K
0
0.00
+62K
+$62K
9-12 Months
3.8M
1.95M
0
0.00
+2.0M
+$1.95M
Top Buyers
Kosasa Thomas
Director
$1.03M
Yu Jeffrey
Director, Officer: Chief Medical Officer
$960K
Casaburi Eric
Director
$31K
Top Sellers
No selling activity
Insider Activity Analysis
Net Insider Sentiment
Strong bullish signal with $2.02M net buying. Insiders are aggressively accumulating shares, suggesting significant confidence in future prospects.
Buy/Sell Ratio
Perfect buy/sell ratio. Only buying activity with zero selling—the most bullish possible insider signal.
Insider Participation
3 insider buyers vs. 0 sellers. Broad-based buying across management team suggests widespread confidence.
Insider Activity Insight
Compelling insider conviction: The combination of strong buy/sell ratio and multiple buyers suggests insiders see attractive risk/reward. Consider this alongside fundamental analysis for confirmation.
SEC Filings
ONMD - Filing history and reports
| Filing Type | Filing Date | Period Ending | Fiscal Year | Actions |
|---|---|---|---|---|
DEF 14A DEF 14A 2025 N/A | November 07, 2025 | November 07, 2025 | 2025 | |
DEF 14A DEF 14A 2024 N/A | November 08, 2024 | November 07, 2024 | 2024 | |
DEF 14A DEF 14A 2023 N/A | August 07, 2023 | August 11, 2023 | 2023 | |
DEF 14A DEF 14A 2022 N/A | October 27, 2022 | November 11, 2022 | 2022 |
Research Paths
Snapshot
Start with context, operating signals, and key market metrics.
Value Model
Stress test fair value across bear, base, and bull assumptions.
Statements
Validate revenue quality, margins, and balance sheet durability.
Earnings Call
Read management commentary and compare it with reported outcomes.
Dividends
Check payout sustainability and long-term distribution behavior.
Analyst Expectations
Review consensus spread and where estimate risk is concentrated.